Pincer-Type Platinum(II) Complexes Containing N-Heterocyclic Carbene (NHC) Ligand: Structures, Photophysical and Anion-Binding Properties, and Anticancer Activities

N,C,N-Pincers in Platinum Bimetallic Complexes: Influence of the Pincer and Bridging Ligands on the Metal-Metal Bond and the Photophysical Properties

Precursors PtCl{κ3-N,C,N-[py-C6HMe2-py]} (1), PtCl{κ3-N,C,N-[py-O-C6H3-O-py]} (2), Pt(OH){κ3-N,C,N-[py-C6HMe2-py]} (3), and Pt(OH){κ3-N,C,N-[py-O-C6H3-O-py]} (4) were used to prepare d8-platinum bimetallic complexes. Precursors 1 and 2 react with AgBF4 and 7-azaindole (Haz) to give [Pt{κ3-N,C,N-[py-C6HMe2-py]}{κ1-N-[Haz]}]BF4 (5) and [Pt{κ3-N,C,N-[py-O-C6H3-O-py]}{κ1-N-[Haz]}]BF4 (6) and 3 and 4 with indolo[2,3-b]indole (H2ii) to generate Pt{κ1-N-[Hii]}{κ3-N,C,N-[py-C6HMe2-py]} (7) and Pt{κ1-N-[Hii]}{κ3-N,C,N-[py-O-C6H3-O-py]} (8). Subsequent addition of 3 and 4 to 5-7 affords bimetallic derivatives [{Pt[κ3-N,C,N-(py-C6HMe2-py)]}2{μ-N,N-[az]}]BF4 (9), [{Pt[κ3-N,C,N-(py-O-C6H3-O-py)]}2{μ-N,N-[az]}]BF4 (10), and {Pt[κ3-N,C,N-(py-C6HMe2-py)]}2{μ-N,N-[ii]} (11). X-ray structures of 9-11 reveal separations between the metals in sequence 9 (3.0515(4) Å) < 10 (3.2689(9) Å) < 11 (3.2949(2) Å). DFT calculations support σ overlap of the dz2 orbitals of platinum atoms, for 9 and 10. Accordingly, their absorption spectra show a MMLCT transition. Complex 9 is a red emitter. The excited state has 3MMLCT characteristics and a Pt-Pt separation of 2.763 Å. Complex 11 is a dual emitter in the red and NIR regions, in solid. Both excited states have a 3LC/LMCT characteristic and platinum-platinum separations of 3.290 and 3.202 Å. Intermediate 5 is a green emitter that achieves quantum yields close to unity, when diluted in PMMA and 1,2-dichloroethane at low concentrations.

A bis(PCN) palladium pincer complex with a remarkably planar 2,5-diarylpyrazine core

A bimetallic Pd complex of a bis(pincer) with a diarylpyrazine core has been prepared. The complex demonstrates near-perfect coplanarity of the aromatic core, is fluorescent under UV irradiation, and displays two quasi-reversible reduction events.

Neutral 2-phenylbenzimidazole-based iridium(III) complexes with picolinate ancillary ligand: tuning the emission properties by manipulating the substituent on the benzimidazole ring

We report the synthesis and characterization of ten neutral bisheteroleptic iridium(III) complexes with 2-phenylbenzimidazole cyclometallating ligand and picolinate as ancillary ligand. The 2-phenylbenzimidazole has been modified by selected substituents introduced on the cyclometallating ring and/or on the benzimidazole moiety. The integrity of the complexes has been assessed by NMR spectroscopy, by high-resolution mass spectrometry and by elemental analysis. The complexes are demonstrated to be highly phosphorescent at room temperature and a luminescence study with comprehensive ab initio calculations allow us to determine the lowest emitting excited state which depends on the substituent nature and its position on the cyclometallating ligand.

Synthesis and Biological Activities of Luminescent 5,6-Membered Bis(Metallacyclic) Platinum(II) Complexes

Four couples of 5,6-membered bis(metallacyclic) Pt(II) complexes with acetylide and isocyanide auxiliary ligands have been prepared and characterized. The structures of (-)-2 and (-)-3 are confirmed by single-crystal X-ray diffraction, showing a distorted square-planar coordination environment around the Pt(II) nucleus. Both solutions and solid samples of all complexes are emissive at RT. Acetylide-coordinated Pt(II) complexes have a lower energy emission than those isocyanide-coordinated ones. The emission spectra of N^N'*C-coordinated Pt(II) derivatives show a lower energy emission maximum relative to N^C*N'-coordinated complexes with the same auxiliary ligand. Moreover, the difference between cyclometalated N^N'*C and N^C*N' ligands exerts a more remarkable effect on the emission than the auxiliary ligands acetylide and isocyanide. Cytotoxicity and cell imaging of luminescent 5,6-membered bis(metallacyclic) Pt(II) complexes have been evaluated.

Competition between N,C,N-Pincer and N,N-Chelate Ligands in Platinum(II)

Replacement of the chloride ligand of PtCl{κ3-N,C,N-[py-C6HR2-py]} (R = H (1), Me (2)) and PtCl{κ3-N,C,N-[py-O-C6H3-O-py]} (3) by hydroxido gives Pt(OH){κ3-N,C,N-[py-C6HR2-py]} (R = H (4), Me (5)) and Pt(OH){κ3-N,C,N-[py-O-C6H3-O-py]} (6). These compounds promote deprotonation of 3-(2-pyridyl)pyrazole, 3-(2-pyridyl)-5-methylpyrazole, 3-(2-pyridyl)-5-trifluoromethylpyrazole, and 2-(2-pyridyl)-3,5-bis(trifluoromethyl)pyrrole. The coordination of the anions generates square-planar derivatives, which in solution exist as a unique species or equilibria between isomers. Reactions of 4 and 5 with 3-(2-pyridyl)pyrazole and 3-(2-pyridyl)-5-methylpyrazole provide Pt{κ3-N,C,N-[py-C6HR2-py]}{κ1-N1-[R'pz-py]} (R = H; R' = H (7), Me (8). R = Me; R' = H (9), Me (10)), displaying κ1-N1-pyridylpyrazolate coordination. A 5-trifluoromethyl substituent causes N1-to-N2 slide. Thus, 3-(2-pyridyl)-5-trifluoromethylpyrazole affords equilibria between Pt{κ3-N,C,N-[py-C6HR2-py]}{κ1-N1-[CF3pz-py]} (R = H (11a), Me (12a)) and Pt{κ3-N,C,N-[py-C6HR2-py]}{κ1-N2-[CF3pz-py]} (R = H (11b), Me (12b)). 1,3-Bis(2-pyridyloxy)phenyl allows the chelating coordination of the incoming anions. Deprotonations of 3-(2-pyridyl)pyrazole and its substituted 5-methyl counterpart promoted by 6 lead to equilibria between Pt{κ3-N,C,N-[pyO-C6H3-Opy]}{κ1-N1-[R'pz-py]} (R' = H (13a), Me (14a)) with a κ-N1-pyridylpyrazolate anion, keeping the pincer coordination of the di(pyridyloxy)aryl ligand, and Pt{κ2-N,C-[pyO-C6H3(Opy)]}{κ2-N,N-[R'pz-py]} (R' = H (13c), Me (14c)) with two chelates. Under the same conditions, 3-(2-pyridyl)-5-trifluoromethylpyrazole generates the three possible isomers: Pt{κ3-N,C,N-[pyO-C6H3-Opy]}{κ1-N1-[CF3pz-py]} (15a), Pt{κ3-N,C,N-[pyO-C6H3-Opy]}{κ1-N2-[CF3pz-py]} (15b), and Pt{κ2-N,C-[pyO-C6H3(Opy)]}{κ2-N,N-[CF3pz-py]} (15c). The N1-pyrazolate atom produces a remote stabilizing effect on the chelating form, pyridylpyrazolates being better chelate ligands than pyridylpyrrolates. Accordingly, reactions of 4-6 with 2-(2-pyridyl)-3,5-bis(trifluoromethyl)pyrrole yield Pt{κ3-N,C,N-[py-C6HR2-py]}{κ1-N1-[(CF3)2C4(py)HN]} (R = H (16), Me (17)) or Pt{κ3-N,C,N-[pyO-C6H3-Opy]}{κ1-N1-[(CF3)2C4(py)HN]} (18), displaying κ1-N1-pyrrolate coordination. Complexes 7-10 are efficient green phosphorescent emitters (488-576 nm). In poly(methyl methacrylate) (PMMA) films and in dichloromethane, they experience self-quenching, due to molecular stacking. Aggregation occurs through aromatic π-π interactions, reinforced by weak platinum-platinum interactions.

Cis and trans platinum(II) N-heterocyclic carbene isomers: synthesis, characterization and biological activity

The synthesis of cis and trans geometrical isomers of platinum(II) complexes with a symmetric N-heterocyclic carbene ligand (MeNHC) is reported. These complexes were obtained from 1,3-dimethylimidazolium-2-carboxylate, a masked NHC precursor....

Dipyrrolyldiketone PtII Complexes: Ion-Pairing π-Electronic Systems with Various Anion-Binding Modes

A variety of π-electronic ion-pairing assemblies can be constructed by combining anion complexes of π-electronic systems and countercations. In this study, a series of anion-responsive π-electronic molecules, dipyrrolyldiketone Pt^II complexes containing a phenylpyridine ligand, were synthesized. The resulting Pt^II complexes exhibited phosphorescence emission, with higher emission quantum yields (0.30-0.42) and microsecond-order lifetimes, and solution-state anion binding, as revealed by our spectroscopic analyses. These Pt^II complexes displayed solid-state ion-pairing assemblies, exhibiting various anion-binding modes, which derived from pyrrole-inverted and pyrrole-non-inverted conformations, and packing structures, with the contribution of charge-by-charge assemblies, which were dependent on the substituents in the Pt^II complexes and the geometries and electronic states of their countercations.

Antitumor activity of tridentate pincer and related metal complexes

Pincer complexes featuring tunable tridentate ligand frameworks are one of the most actively studied classes of metal-based complexes. Currently, growing attention is devoted to the cytotoxicity of pincer and related metal complexes. The antiproliferative activity of numerous pincer complexes has been reported. Pincer tridentate ligand scaffolds show different coordination modes and offer multiple options for directed structural modifications. This review summarizes the significant progress in the research studies of the antitumor activity of pincer and related platinum(ii), gold(iii), palladium(ii), copper(ii), iron(iii), ruthenium(ii), nickel(ii) and some other metal complexes, in order to provide a reference for designing novel metal coordination drug candidates with promising antitumor activity.

Platinum(II) N-heterocyclic carbene complexes arrest metastatic tumor growth

Vimentin is a cytoskeletal intermediate filament protein that plays pivotal roles in tumor initiation, progression, and metastasis, and its overexpression in aggressive cancers predicted poor prognosis. Herein described is a highly effective antitumor and antimetastatic metal complex [Pt^II(C^N^N)(NHC^2Bu)]PF₆ (Pt1a; HC^N^N = 6-phenyl-2,2'-bipyridine; NHC= N-heterocyclic carbene) that engages vimentin via noncovalent binding interactions with a distinct orthogonal structural scaffold. Pt1a displays vimentin-binding affinity with a dissociation constant of 1.06 µM from surface plasmon resonance measurements and fits into a pocket between the coiled coils of the rod domain of vimentin with multiple hydrophobic interactions. It engages vimentin in cellulo, disrupts vimentin cytoskeleton, reduces vimentin expression in tumors, suppresses xenograft growth and metastasis in different mouse models, and is well tolerated, attributable to biotransformation to less toxic and renal-clearable platinum(II) species. Our studies uncovered the practical therapeutic potential of platinum(II)‒NHC complexes as effective targeted chemotherapy for combating metastatic and cisplatin-resistant cancers.

Luminescent cyclometalated platinum(ii) complexes with acyclic diaminocarbene ligands: structural, photophysical and biological properties

Four new cyclometalated Pt(ii) complexes bearing acyclic diaminocarbene (ADC) ligands, [Pt(C^N)Cl{C(NHXyl)(NHR)}] [C^N = 2,6-difluorophenylpyridine (dfppy), phenylquinoline (pq); R = Pr 3a, 4a, CH₂Ph 3b, 4b], were prepared by the nucleophilic attack on the isocyanide [Pt(C^N)Cl(CNXyl)] (C^N = dfppy 1, pq 2) by the corresponding amine RNH₂ (R = Pr, CH₂Ph). Complexes 3 show in their ¹H NMR spectra in CDCl₃ a notable concentration dependence, with a clear variation of the δ_H (NHXyl) signal, suggesting an assembling process implying donor-acceptor NH_XylCl bonding, also supported by 1D-PGSE (Pulse Field Gradient Spin Echo) and 2D-DOSY (Diffusion Ordered Spectroscopy) NMR experiments in solution and X-ray diffraction studies. The intermolecular interactions in compounds 3a and 3b were studied by using Hirshfeld surface analysis and Non-Covalent Interaction (NCI) methods on their X-ray structures. Their photophysical properties were investigated by absorption and emission spectroscopies and also by TD-DFT calculations performed on 3a and 4b. These complexes show green (3) or orange (4) phosphorescence, attributed to a mixed ³IL/³MLCT excited state. The carbene ligand does not affect the emission maxima but it produces an increase of the quantum yields in relation to the isocyanide in the precursors. In fluid solutions, the emission is not concentration-dependent, but the complexes may show aggregation induced emission as detailed for complexes 3a and 4a. In addition, cytotoxicity studies in the human cell lines A549 (lung carcinoma) and HeLa (cervix carcinoma) showed good activity for these complexes and 3a, 3b and 4a exhibit a strong effect on DNA electrophoretic mobility. To the best of our knowledge, compounds 3 and 4 represent the first examples of cycloplatinated complexes bearing acyclic diamino carbenes with antiproliferative properties.

Luminescent Quantum Dots Stabilized by N-Heterocyclic Carbene Polymer Ligands

We have tested the ability of N-heterocyclic carbene (NHC)-modified ligands to coordinate and stabilize luminescent CdSe-ZnS core-shell quantum dot (QD) dispersions in hydrophilic media. In particular, we probed the effects of ligand structure and coordination number on the coating affinity to the nanocrystals. We find that such NHC-based ligands rapidly coordinate onto the QDs (requiring ∼5-10 min of reaction time), which reflects the soft Lewis base nature of the NHC groups, with its two electrons sharing capacity. Removal of the hydrophobic cap and promotion of carbene-driven coordination on the nanocrystals have been verified by ¹H NMR spectroscopy, while ¹³C NMR was used to identify the formation of carbene-Zn complexes. The newly coated QD dispersions exhibit great long-term colloidal stability over a wide range of conditions. Additionally, we find that coordination onto the QD surfaces affects the optical and spectroscopic properties of the nanocrystals. These include a size-dependent red-shift of the absorption and fluorescence spectra and a pronounced increase in the measured fluorescence intensity when the samples are stored under white light exposure compared to those stored in the dark.

Influence of Ligand and Nuclearity on the Cytotoxicity of Cyclometallated C^N^C Platinum(II) Complexes

A series of cyclometallated mono- and di-nuclear platinum(II) complexes and the parent organic ligand, 2,6-diphenylpyridine 1 (HC^N^CH), have been synthesized and characterized. This library of compounds includes [(C^N^C)PtII (L)] (L=dimethylsulfoxide (DMSO) 2 and triphenylphosphine (PPh3 ) 3) and [((C^N^C)PtII )2 (L')] (where L'=N-heterocycles (pyrazine (pyr) 4, 4,4'-bipyridine (4,4'-bipy) 5 or diphosphine (1,4-bis(diphenylphosphino)butane (dppb) 6). Their cytotoxicity was assessed against four cancerous cell lines and one normal cell line, with results highlighting significantly increased antiproliferative activity for the dinuclear complexes (4-6), when compared to the mononucleated species (2 and 3). Complex 6 is the most promising candidate, displaying very high selectivity towards cancerous cells, with selectivity index (SI) values >29.5 (A2780) and >11.2 (A2780cisR), and outperforming cisplatin by >4-fold and >18-fold, respectively.

Novel nickel(II), palladium(II), and platinum(II) complexes having a pyrrolyl-iminophosphine (PNN) pincer: Synthesis, crystal structures, and cytotoxic activity

A pyrrolyl-iminophosphine (PNNH) which would act as a potential terdentate ligand has been prepared by Schiff base reaction. Complexes [M(PNN)X] (M = Ni; X = Cl (1), Pd; X = Cl (2), Br (3), I (4), M = Pt; X = Cl (5)) were prepared. The title complexes were characterized by various spectroscopic (IR, ¹H, ¹³C, and ³¹P NMR) and elemental analyses. The molecular structures of 1, 2, and 5 have been established by single-crystal X-ray crystallography, demonstrating a distorted square planar geometry comprising two 5-membered metallacyclic rings. Complexes 1 and 2 were found to crystallize in the orthorhombic while complex 5 crystallizes in the monoclinic. Cytotoxicities of the complexes along with PNNH were evaluated against A549 (lung), SK-OV-3 (ovarian), SM-MEL-2 (skin), and HCT15 (colon) human cancer cell lines by sulforhodamine B assay. Notably, the palladium(II) complex (2) shows the highest activity. Apoptosis activity along with the caspase inhibitor Z-VAD (Z-Val-Ala-Asp-fluoromethyl ketone) assay of 2 and 5 against A549 and HCT15 cancer cell lines were investigated to learn a mechanistic pathway for the observed cytotoxicity, practically eliminating an apoptotic cell-death route. Complexes 2 and 5 were studied to DNA cleavage assay and molecular docking simulation. The DNA (pcDNA3.0) cleavage experiment evaluates complex 5 interacting with DNA, more effectively, in comparison to complex 2. Molecular docking simulation of 2 and 5 toward DNA and GRP78 (glucose-regulated protein 78) was performed to predict binding sites of ligand-receptors and a plausible mechanistic aspect of metallodrug-action.

End-grafted Cu-NNN pincer complexes on PAMAM dendrimers-SiO2: synthesis and characterization

A triazine-derived Cu(ii)-NNN pincer complex was linked onto dendritic nanoparticle supports.

Mitochondria-Targeting Anticancer Metal Complexes

Background:

Since the serendipitous discovery of the antitumor activity of cisplatin there has been a continuous surge in studies aimed at the development of new cytotoxic metal complexes. While the majority of these complexes have been designed to interact with nuclear DNA, other targets for anticancer metallodrugs attract increasing interest. In cancer cells the mitochondrial metabolism is deregulated. Impaired apoptosis, insensitivity to antigrowth signals and unlimited proliferation have been linked to mitochondrial dysfunction. It is therefore not surprising that mitochondria have emerged as a major target for cancer therapy. Mitochondria-targeting agents are able to bypass resistance mechanisms and to (re-) activate cell-death programs.

Methods:

Web-based literature searching tools such as SciFinder were used to search for reports on cytotoxic metal complexes that are taken up by the mitochondria and interact with mitochondrial DNA or mitochondrial proteins, disrupt the mitochondrial membrane potential, facilitate mitochondrial membrane permeabilization or activate mitochondria-dependent celldeath signaling by unbalancing the cellular redox state. Included in the search were publications investigating strategies to selectively accumulate metallodrugs in the mitochondria.

Results:

This review includes 241 references on antimitochondrial metal complexes, the use of mitochondria-targeting carrier ligands and the formation of lipophilic cationic complexes.

Conclusion:

Recent developments in the design, cytotoxic potency, and mechanistic understanding of antimitochondrial metal complexes, in particular of cyclometalated Au, Ru, Ir and Pt complexes, Ru polypyridine complexes and Au-N-heterocyclic carbene and phosphine complexes are summarized and discussed.

Synthesis of bimetallic complexes bridged by 2,6-bis(benzimidazol-2-yl) pyridine derivatives and their catalytic properties in transfer hydrogenation

A series of binuclear rhodium(i) and iridium(i) complexes with 2,6-bis(benzimidazol-2-yl) pyridine (bzimpy) derivatives were synthesized and characterized by elemental analysis and spectroscopic methods. The molecular and crystal structures of complex 3d were determined by the single crystal X-ray diffraction technique. Their monometallic analogues were prepared to compare the catalytic properties of the bimetallic complexes. To determine the catalyst properties that result in a cooperative, bimetallic enhancement of the reaction rate, the systematic variation of the intermetallic distance and the ligand donor properties of the bimetallic complexes were explored based on the transfer hydrogenation reactions of ketones.

4,5-Substituted C^C* cyclometalated thiazol-2-ylidene platinum(ii) complexes - synthesis and photophysical properties

We report the synthesis of seven novel backbone functionalized N-phenyl-1,3-thiazol-2-ylidene platinum(ii) complexes and their photophysical properties. Electronically diverse N-phenyl-1,3-thiazol-2-thiones were prepared by a reaction of aniline with carbon disulfide and different α-haloketone compounds. Oxidative desulfuration and salt metathesis yielded the desired NHC-precursors with hexafluorophosphate counterions. In addition, a new route for the synthesis of N-phenyl-1,3-benzo[d]thiazole tetrafluoroborate via N-arylation using hypervalent iodine species is presented. All complexes were prepared from the corresponding NHC precursor in a one-pot process using silver(i)oxide, transmetalation to platinum and reaction with the β-diketone acetylacetone under basic conditions. These complexes exhibit strong phosphorescence with quantum yields up to 72% in 2 wt% PMMA films with decay lifetimes of 8.8-12.3 μs. The influence of methyl- and phenyl-groups, and an ester-substituent at the 4- and/or 5-position of the 1,3-thiazole moiety, as well as the N-phenyl-1,3-benzo[d]thiazole-derived motif is discussed. The 4,5-unsubstituted-N-phenyl-1,3-thiazol-2-ylidene platinum(ii) acetylacetonato complex served as a reference in this study to evaluate the electronic effects originating from the backbone substitution. All complexes emit in a narrow range of the bluish-green spectrum of the visible light (510 ± 10 nm).

Luminescent cyclometallated platinum(ii) complexes: highly promising EGFR/DNA probes and dual-targeting anticancer agents

Cyclometallated platinum complexes bearing 4-anilinoquinazolines exhibit high potential as luminescent probes for EGFR/DNA in living cells and dual-targeting anticancer agents.

Cyclometalated Gold(III) Complexes Containing N-Heterocyclic Carbene Ligands Engage Multiple Anti-Cancer Molecular Targets

Metal N-heterocyclic carbene (NHC) complexes are a promising class of anti-cancer agents displaying potent in vitro and in vivo activities. Taking a multi-faceted approach employing two clickable photoaffinity probes, herein we report the identification of multiple molecular targets for anti-cancer active pincer gold(III) NHC complexes. These complexes display potent and selective cytotoxicity against cultured cancer cells and in vivo anti-tumor activities in mice bearing xenografts of human cervical and lung cancers. Our experiments revealed the specific engagement of the gold(III) complexes with multiple cellular targets, including HSP60, vimentin, nucleophosmin, and YB-1, accompanied by expected downstream mechanisms of action. Additionally, Pt^II and Pd^II analogues can also bind the cellular proteins targeted by the gold(III) complexes, uncovering a distinct pincer cyclometalated metal-NHC scaffold in the design of anti-cancer metal medicines with multiple molecular targets.

Design of a flexible organometallic tecton: host–guest chemistry with picric acid and self-assembly of platinum macrocycles

A new “flexible” and ditopic Pt(ii) organometallic compound is a tecton for the self-assembly of neutral metallacycles. It also exhibits significant binding affinity for picric acid.

Changing the Emission Properties of Phosphorescent C^C*-Cyclometalated Thiazol-2-ylidene Platinum(II) Complexes by Variation of the β-Diketonate Ligands

Cyclometalated thiazol-2-ylidene platinum(II) complexes based on the N-phenyl-4,5-dimethyl-1,3-thiazol-2-ylidene N-heterocyclic carbene (NHC) ligand and seven different β-diketonate ligands have been synthesised and investigated for their structural and photophysical properties. The complexes were synthesised in a one-pot procedure starting with the in situ formation of the corresponding silver(I) carbene and transmetalation to platinum, followed by the reaction with the respective β-diketonate under basic conditions. All the compounds were fully characterised by standard techniques, including ¹⁹⁵ Pt NMR spectroscopy. Three solid-state structures revealed quite different aggregation behaviour depending on the β-diketonate architecture. The reported complexes showed strong phosphorescence at room temperature in amorphous poly(methyl methacrylate) films. The emission wavelengths (ca. 510 nm) were found to be independent of the β-diketonate ligand, but the electronically diverse β-diketonates strongly influence the observed quantum yields (QY) and decay lifetimes. The results of theoretical studies employing density functional theory (DFT) methods support the conclusion of a metal-to-ligand charge transfer (³ MLCT) as the main emission process, in accordance with the reported photophysical properties. Standard organic light-emitting diodes (OLEDs) prepared with unoptimised matrix materials using one of the complexes showed values of 12.3 % external quantum yield, 24.0 lm W^-1 luminous efficacy and 37.8 cd A^-1 current efficiency at 300 cd m^-2 .

Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold

Couples of N-heterocyclic carbene complexes of ruthenium, iridium, platinum, and gold, each differing only in the carbene ligand being either 1,3-dimethylimidazol-2-ylidene (IM) or 1,3-dimethyl-N-boc-O-methylhistidin-2-ylidene (HIS), were assessed for their antiproliferative effect on seven cancer cell lines, their interaction with DNA, their cell cycle interference, and their vascular disrupting properties. In MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assays only the platinum complexes were cytotoxic at single-digit micromolar IC₅₀ concentrations with the (HIS)Pt complex being on average twice as active as the (IM)Pt complex. The former was highly efficacious against cisplatin-resistant HT-29 colon carcinoma cells where the latter had no effect. Both Pt complexes were accumulated by cancer cells and bound to double-helical DNA equally well. Only the (HIS)Pt complex modified the electrophoretic mobility of circular DNA in vitro due to the HIS ligand causing greater morphological changes to the DNA. Both platinum complexes induced accumulation of 518A2 melanoma cells in G2/M and S phase of the cell cycle. A disruption of blood vessels in the chorioallantoic membrane of fertilized chicken eggs was observed for both platinum complexes and the (IM)gold complex. The (HIS)platinum complex was as active as cisplatin in tumor xenografted mice while being tolerated better. We found that the HIS ligand may augment the cytotoxicity of certain antitumoral metal fragments in two ways: by acting as a transmembrane carrier increasing the cellular accumulation of the complex, and by initiating a pronounced distortion and unwinding of DNA. We identified a new (HIS)platinum complex which was highly cytotoxic against cancer cells including cisplatin-resistant ones.

Stable luminescent iridium(iii) complexes with bis(N-heterocyclic carbene) ligands: photo-stability, excited state properties, visible-light-driven radical cyclization and CO2 reduction, and cellular imaging

Excited state properties, photo-catalysis and cellular imaging of photo-stable bis-NHC Ir(iii) complexes are described.

A new class of cyclometalated Ir(iii) complexes supported by various bidentate C-deprotonated (C^N) and cis-chelating bis(N-heterocyclic carbene) (bis-NHC) ligands has been synthesized. These complexes display strong emission in deaerated solutions at room temperature with photoluminescence quantum yields up to 89% and emission lifetimes up to 96 μs. A photo-stable complex containing C-deprotonated fluorenyl-substituted C^N shows no significant decomposition even upon irradiation for over 120 h by blue LEDs (12 W). These, together with the strong absorption in the visible region and rich photo-redox properties, allow the bis-NHC Ir(iii) complexes to act as good photo-catalysts for reductive C–C bond formation from C(sp³/sp²)–Br bonds cleavage using visible-light irradiation (λ > 440 nm). A water-soluble complex with a glucose-functionalized bis-NHC ligand catalysed a visible-light-driven radical cyclization for the synthesis of pyrrolidine in aqueous media. Also, the bis-NHC Ir(iii) complex in combination with a cobalt catalyst can catalyse the visible-light-driven CO₂ reduction with excellent turnover numbers (>2400) and selectivity (CO over H₂ in gas phase: >95%). Additionally, this series of bis-NHC Ir(iii) complexes are found to localize in and stain endoplasmic reticulum (ER) of various cell lines with high selectivity, and exhibit high cytotoxicity towards cancer cells, revealing their potential uses as bioimaging and/or anti-cancer agents.